DERMATA THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
DERMATA THERAPEUTICS, INC. (DRMA) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$1.59 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-26
- DERMATA THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$1.59K.
- DERMATA THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$2.58K.
- DERMATA THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$1.64M.
- DERMATA THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$2.02M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$1.59K 10-K · filed 2026-03-26 | |
| 2024-12-31 | -$2.58K 10-K · filed 2026-03-26 | -$2.58M 10-K · filed 2025-03-17 |
| 2023-12-31 | -$1.64M 10-K · filed 2025-03-17 | |
| 2022-12-31 | -$2.02M 10-K · filed 2024-03-21 | -$2.02K 10-K · filed 2023-02-21 |
| 2021-12-31 | -$1.66M 10-K · filed 2023-02-21 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |